Introduction
Individuals diagnosed with chronic kidney disease (CKD) who require maintenance hemodialysis (MHD) may experience hypermetabolism, [1] [2] [3] [4] resulting in an increased energy expenditure that contributes to their higher risk for protein-energy wasting and poor clinical outcomes. [5] [6] [7] [8] To ensure that the practitioner prescribes an appropriate caloric recommendation for optimal health, the methods to determine energy expenditure must be standardized, reliable, and accurate.
In the clinical setting, indirect calorimetry (IC) is considered the "gold standard" method to measure resting energy 660981P ENXXX10.1177/0148607116660981Journal of Parenteral and Enteral NutritionOlejnik et al research-article2016 expenditure (REE). [9] [10] [11] [12] Under resting conditions, oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) are measured by IC. These values, in turn, are imputed into the Weir equation 13 to derive the measured REE (mREE). 10, 12, 14 To yield the most precise results, IC is ideally measured over a consecutive 24-hour period. However, this methodological approach is not feasible within the clinical setting.
14 Thus, the concept of a steady state (SS) interval was first proposed by McClave et al. 15 These researchers documented that a shortened time interval of IC measurement (eg, 20, 30, 40 minutes) represents mREE data obtained over a 24-hour period and does reflect mREE at a baseline physiologic state. 15 An SS interval is established within 1-minute increments and is a period whereby the mean VO 2 and VCO 2 change by less than a predetermined percentage range (eg, ≤10%).
14 The most widely accepted and stringent SS definition among mechanically ventilated patients includes an IC test that collects 10 consecutive minutes and then discards the first 5 minutes of data, with the remaining 5 minutes required to achieve a coefficient of variation (CV) of VO 2 and VCO 2 . 16 Satisfying this SS criterion generally requires at least 20-30 minutes of continuous testing.
In some debilitated conditions, such as traumatic brain injury 17 and cancer, 18 whereby it is difficult to achieve SS for an extended period, abbreviated SS intervals (≤5 min) have been published. According to our own research observations, we identified that some participants who were diagnosed with CKD on MHD were unable to achieve an SS interval for an extended period (eg, 10 minutes). Thus, we were uncertain whether current criteria for SS were reasonable for such a medically complex population. At the time of this investigation, there was no available literature to inform our decisions in terms of SS criteria specific to the CKD patient group. Hence, our objective was to explore whether we could shorten the SS interval without introducing bias or error, by comparing the level of agreement between the shortened intervals (5, 4, 3, and 2 minutes) and a standard reference interval (eg, 10 minutes).
Materials and Methods

Subjects and Design
The current study was a cross-sectional secondary analysis of data (N = 125) collected from a 3-year federally funded study that developed and validated a predictive energy equation for hemodialysis patients. In the original study, participants were recruited from dialysis clinics associated with nephrology teams from Rutgers University, Case Western Reserve University, and Pennsylvania State University-Hershey Medical Center. Participants were screened for eligibility if they were adults (≥18 years), were diagnosed with stage 5 CKD, received MHD thrice weekly for a minimum of 3 months, and were able to answer study-related questions. Exclusion criteria were as follows: a hospitalization, surgical/elective procedure, or any cardiacrelated event within the past 30 days from enrollment; a cardiac implantable device; infection or nonhealing wound; active malignancy; treatment by peritoneal dialysis, shortened daily hemodialysis, nocturnal hemodialysis, or kidney transplant with prescribed immunosuppressive agents; pregnancy, lactating, or <3 months postpartum; and/or reported use of substances known to affect metabolic rate. Informed consent-which followed Institutional Review Board requirements at each research site (Case Western Reserve University 08-12-37, Pennsylvania State University-Hershey Medical Center 40781EP, and Rutgers University 2012001976)-was obtained from those willing to participate and meeting eligibility criteria.
Interrater and Intrarater Reliability and Training Calibration
To ensure interrater and intrarater reliability, a 2-day training/ calibration session was arranged before recruitment and enrollment efforts were launched at any of the 3 research sites. The primary objective of this training session was to demonstrate the correct procedures for each proposed measurement, as well as to afford the investigators the ability to acquire hands-on skills for collecting such measurements on "control" patients. The demonstrations were digitally videotaped with the files shared so that they could be viewed at later times in case any questions were raised regarding the correct technique. In addition, each study investigator received a study protocol manual that gave detailed procedures on the methods involved within the proposed project. Once data collection began, the lead investigators at each research site monitored the study protocol closely. Over the course of the 3-year study, there were scheduled visits to each site by the principal investigator with the intent of ensuring quality control and oversight, as well as to confirm that procedures were followed and standardized from one research site to the next. Coinvestigators met weekly via teleconferencing to discuss recruitment, enrollment, and methodological procedures and to address any issues or questions. All study equipment was calibrated and tested per factory specifications prior to participant testing.
Measurements
As part of the original study, each participant had testing completed on a nonhemodialysis treatment day at a designated research site, which included the following: (1) REE measurement with the IC device (ie, metabolic cart); (2) body composition analysis with bioelectrical impedance; (3) clinical measurements (eg, height, weight, waist and hip circumferences, blood pressure, respiration rate, heart rate, and body temperature); (4) collection of laboratory samples for analysis (eg, glycosylated hemoglobin, C-reactive protein, serum creatinine); and (5) 
Measurement of REE
Evidence-based recommendations published by the Academy of Nutrition and Dietetics for conducting IC studies were followed. 19 Participants were instructed to avoid vigorous physical activity for 12 hours prior to the metabolic measurements. Participants were also asked to fast for the same period, but if such a fast was not medically feasible, a 4-hour fast was deemed acceptable. To ensure that most of the fasting occurred while the participant slept, measurements were obtained in the morning or soon after they had arisen from sleep. The IC measurements were completed in a quiet, comfortable room after the participant had been in a recumbent position for a minimum of 20 minutes. Participants were instructed to avoid fidgeting, hyperventilating, or sleeping during the test. The measurement was initiated by placing a rigid plastic canopy over the participant's head or by using a face mask with an airtight seal so that the expired gas could be captured and directed into the calorimeter. A 15-minute interval was initially used, with the first 5 minutes automatically discarded. The remaining 10 minutes of measured values were collected so that the SS threshold of ≤10% CV for oxygen consumption and carbon dioxide production was achieved. If this threshold was not reached, the measurement was extended to 30 minutes in an attempt to reach the 10% threshold.
The IC devices (ie, metabolic carts) used for the original study included the Quark RMR (Cosmed, Rome, Italy) at both Rutgers University and Pennsylvania State UniversityHershey Medical Center and the Vmax Encore (CareFusion, Yorba Linda, CA) at Case Western Reserve University. Ashcraft and Frankenfield validated the Quark RMR for measuring REE. 20 The Vmax Encore and the Quark RMR were also tested for reliability and found to be comparable devices. 
SS Intervals
This study defined an SS interval as a consecutive period in minutes during the IC test where the CV was ≤10% for average VO 2 and VCO
2
. SS was measured in intervals of 10, 5, 4, 3, and 2 minutes. We used the criterion measure of a 10-minute SS interval based on the work of McClave et al. 15 We felt that it would be too onerous for the participants to conduct a 60-minute IC test for the purpose of evaluating longer SS intervals (eg, 20, 30, and 40 minutes). However, we wanted a reasonably precise measure of REE for which to index the shortened SS protocols. If SS was not achieved, then mREE could not be calculated for the desired time interval. The minute-by-minute recordings of VCO 2 and VO 2 were evaluated to determine if each time interval achieved SS condition (ie, ≤10% CV over the interval). Data were validated by simultaneously monitoring the respiratory gases within context of the RQ at a physiologic range of 0.8-1.3 and the participant's total tidal volume. 18, 22 As described by Reeves et al, 18 the averaged VO 2 , VCO 2 , and RQ values were recorded for each SS interval so that the mREE could be derived by the Weir equation. 13 If the participant achieved SS more than once during the entire IC test, the first time interval when SS occurred was selected for analysis. mREE for each SS time interval (10, 5, 4, 3, and 2 minutes) represented the average of the mREE measurements derived by the minute-by-minute recordings.
Statistical Analysis
Level of significance was set at an alpha ≤0.05. Continuous variables were tested for normality and reported as mean ± SD unless otherwise stated. Per Bland and Altman's procedure for testing agreement, mean bias (mean difference between mREEs at 10-minute SS and each SS time interval) was tested with a 1-sample t test for each period. 23 BlandAltman plots were used to describe the level of agreement between mREEs at 10-minute SS and each shorter period measurement. Limits of agreement, set at 95% CI, were used to determine if the compared data were interchangeable. 18, 23 Current publications report that mREE values, within the MHD population, typically vary between 5%-18% as compared with control subjects. 2, 24, 25 Due to the variance in mREE, an additional limit of agreement was set at ±10% of mean mREE for the 10-minute SS interval for individuals who met SS parameters for each comparable grouping. A mean difference (of mREE) close to zero suggested a good level of agreement. [16] [17] [18] 26 
Results
Active participant recruitment and enrollment began in June 2013 with 1123 prospective participants recruited and referred over the course of the 3 years. Of this total number, 726 resulted in screening failures (64.6%) with 208 participants (18.5%) consented and enrolled; however, 83 of these participants (39.9%) withdrew, did not show for research appointments, or were unable to complete IC testing. The higher attrition rate occurred during the winter months and was partially attributed to inclement weather that caused the closing of university campuses. At the close of the grant cycle in August 2015, 125 participants had been measured with IC data available for the current study. The sample (N = 125) was primarily male, African American, and non-Hispanic with a mean age of 55.4 ± 12.2 years ( Table 1 ). The most frequent etiology for CKD was hypertension, followed by diabetes. Dialysis vintage was, on average, 62.4 ± 74.3 months.
Bias
The number of participants able to achieve the SS definition for the predefined time intervals varied (Table 2) . Of the total sample, 72.0% were able to achieve SS at the 10-minute interval, 83.2% at 5 minutes, 87.2% at 4 minutes, and 89.6% for both 3 and 2 minutes. Participants who did not meet a 10-minute SS (n = 35) were compared with those who did (n = 90) across demographic and clinical characteristics. No statistically significant differences were identified. Similarly, whether or not a participant achieved a 10-minute SS was not significantly associated with the device used. None of the mREE mean measures were significantly different from that of the 10-minute SS interval (Table 2 ). With the exception of the 3-minute SS interval, all abbreviated SS intervals were close to zero. There was no significant bias detected between the 10-minute SS interval and shorter measurement periods. However, the SS intervals of 5, 4, 3, and 2 minutes did show greater variability when compared with the reference value (10-minute SS).
Agreement
In Figures 1-4 , the mean bias is represented by the solid line and the 95% CI by the long-dashed lines. Lines very close to 0 on the y-axis indicate low bias. The short-dashed lines indicate the reference period (10 minutes) within the 10% band of agreement (±150.3). For the 3-minute interval, 3 (3.3%) participants had differences that were not within the limits of agreement. For the 5-minute and 2-minute intervals, 2 participants (2.2%) fell outside the 10% band. Only 1 participant (1.1%) did not achieve the band of acceptability for the 4-minute interval. The 95% CIs of the mean difference between the interval measures increase as comparison intervals shorten.
Discussion
Achievement of SS during IC testing ensures better precision in the REE measurement. McClave and colleagues verified that IC tests <24 hours (eg, 20-60 minutes) represent true physiologic energy expenditure. 15 However, when SS is unobtainable during the IC testing period, such data cannot be used for determining mREE. Too often, strict SS criteria cited in the literature cannot be achieved by medically complex patients. 17, 18 These challenges, as well as the barriers related to lack of equipment and training, can lead to the impracticability of IC within the clinical care setting and can cause practitioners to rely on predictive energy equations that may not be validated for use within their specific patient populations. In our study, approximately one-fourth (28%, n = 35) of the participants could not achieve the SS definition of ≤10% CV for VO 2 and VCO 2 for a 10-minute test. Since our experience with the CKD population may have larger research and clinical implications, we sought to determine whether shorter periods (5, 4, 3, and 2 minutes) under the same criteria (CV ≤10%), which may be more achievable, would establish additional SS protocols that meet clinically acceptable standards.
According to our study sample, there were nonsignificant differences between the shortened SS time intervals and our standard reference criterion of 10 minutes. Given the intervariability of mREE among patients on MHD (anywhere from 5%-18%), 1,2 we expanded our limits of agreement to ±10% of the 10-minute mean mREE. Others, such as Reeves et al, 18 employed a much tighter band of acceptability in light of their patient populations (±2%) due to the consequent implications of inaccurately determining mREE among those with traumatic brain injury. All of the shortened SS intervals demonstrated bias close to zero, with the exception of the 3-minute SS interval, but the differences were not significant. These findings replicate those of earlier investigations 17, 18 among spontaneously breathing individuals diagnosed with chronic or critical illness such that abbreviated intervals for SS are likely a reasonable alternative to a longer, more stringent SS definition.
As mentioned, >25% of our sample was not able to achieve SS at a 10-minute interval. Although these participants were excluded from the analysis, there were no statistically significant differences in the demographic or clinical characteristics in the analysis and the characteristics of the total sample. We were not able to identify any differences in the gas exchange patterns between subjects who achieved 10-minute and those who did not satisfy the established criterion. Incidentally, a greater proportion of participants in our study reached SS at the abbreviated intervals than in other investigations among spontaneously breathing individuals 17, 18 and was comparable to studies of critically ill, ventilator-dependent patients. 15, 16, 26 It typically takes spontaneously breathing participants time to acclimate to the IC testing and have relaxed, regular breathing patterns, whereas mechanically ventilated patients have their gas exchange externally controlled and manipulated. 12, 26 Nonetheless, as shown in other ambulatory populations, reducing the SS time interval increased the proportion of participants who achieved SS, without significant differences in their mREEs. 17, 18 We are, however, cautious in the wide application of an abbreviated SS interval (<5 minutes) into clinical practice solely on the basis of our findings. In fact, our results confirm the earlier work by McClave et al. 15 Thus, clinicians can accept an mREE among patients on MHD for an SS interval of 5 minutes with ≤10% CV when the 10-minute SS interval cannot be achieved, but using abbreviated SS time intervals (<5 minutes) requires further investigation.
Even though achievement of SS is essential for ensuring stable gas exchange parameters, it is not enough to precisely measure REE. There are several potentially negative influencing factors on mREE, such as the possibility of air leaks, an inaccurate calibration of the IC device, erratic breathing patterns of the participant, or abnormal levels of fractionally inspired oxygen in ventilated-dependent patients. 12 Thus, monitoring RQ, which has an accepted known physiologic range, may aid in determining the validity of the IC test and its respective data. 17, 22 Seemingly, RQ values outside of range may be questioned and therefore render, even if at SS, an IC test as invalid. During the IC test, such values were analyzed, including total tidal volume, so that such SS data were valid and the REE measurements accurately derived. Additionally, to ensure higher confidence in our IC measurements, we meticulously calibrated the flow sensors and gas analyzers prior to every test obtained, and we adhered to evidence-based practice guidelines regarding the conditions for successful completion of IC testing. 19 While there was variability in the IC device used by the research institutions (Quark RMR vs Vmax Encore), there were no significant differences in the proportion of participants who were able to achieve SS at either the reference standard (10 minutes) or any of the abbreviated time intervals (5, 4, 3, or 2 minutes) by site or device. The comparability, reliability, and validity of these 2 devices have been reported. 20, 21 In addition, the one research site that used the Vmax Encore also measured the participants using a well-fitted, airtight face mask. While the canopy hood is less prone to air leaks, 27 ,28 the participants measured via the face mask were closely monitored to ensure that the gas exchange was not compromised.
In light of our findings, some limitations warrant careful interpretation. Our sample was not a generalizable sample of patients on MHD. Younger male individuals (predominate in our sample) may have had a very different experience achieving SS than females or older persons. Thus, this study should be repeated with a more diverse population to confirm that key demographic or clinical characteristics do not preclude the accurate REE measurement of patients with CKD on MHD and to increase confidence that our results are reproducible. While we were not able to detect any substantive differences in the IC devices (Quark RMR vs Vmax Encore) used or the procedures employed (canopy hood vs face mask), greater standardization of IC testing protocols would only strengthen our confidence with the findings disseminated. Despite these limitations, we are the first team that has studied the ability to achieve a precise measure of REE while reducing or abbreviating the SS interval time in the MHD population. In summary, we conclude that reducing the period of SS to <10 minutes (eg, 5 minutes) may be a reasonably precise alternative for measuring REE. Future studies could further evaluate the ability of an abbreviated SS interval at minimizing patient burden and reducing overall research time dedicated to obtaining such data. 
